Bunyaviruses: From transmission by arthropods to virus entry into the mammalian host first-target cells

Future Virology

Volumn 10, Issue 7, 2015, Pages 859-881

  Léger, Psylvia ^a   Lozach, Pierre Yves ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

arbovirus; arthropod; bunyavirus; cell entry; emerging disease; transmission; vector

Indexed keywords

VIRUS PROTEIN;

ARTHROPOD; BUNYAVIRIDAE; BUNYAVIRUS INFECTION; GENOME ANALYSIS; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TARGET CELL; VIRION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS TRANSMISSION;

ANIMALIA; ARBOVIRUS; ARTHROPODA; BUNYAVIRIDAE; MAMMALIA; ORTHOBUNYAVIRUS; RNA VIRUSES; VERTEBRATA;

EID: 84938685559     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.15.52     Document Type: Review

References (199)

1. Schmaljohn C, Elliott RM. Bunyaviridae. In: Fields Virology. Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, Philadelphia, 1244-1282 (2014).
2. Blakqori G, Bouloy M, Bridgen A et al. Bunyaviridae: molecular and cellular Biology. Plyusnin A, Elliott RM (Eds). Caister Academic Press (2011).
3. Cifuentes-Munoz N, Salazar-Quiroz N, Tischler ND. Hantavirus gn and gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses 6(4), 1801-1801 (2014).
4. Holmes EC, Zhang YZ. The evolution and emergence of hantaviruses. Curr. Opin. Virol. 10C, 27-33 (2015).
5. Elliott RM. Orthobunyaviruses: recent genetic and structural insights. Nat. Rev. Microbiol. 12(10), 673-685 (2014).
6. Elliott RM, Brennan B. Emerging phleboviruses. Curr. Opin. Virol. 5, 50-57 (2014).
7. Lasecka L, Baron MD. The molecular biology of nairoviruses, an emerging group of tick-borne arboviruses. Arch Virol 159(6), 1249-1265 (2014).
8. Conraths FJ, Peters M, Beer M. Schmallenberg virus, a novel orthobunyavirus infection in ruminants in Europe: potential global impact and preventive measures. NZ Vet. J. 61(2), 63-67 (2013).
9. Junglen S, Drosten C. Virus discovery and recent insights into virus diversity in arthropods. Curr. Opin. Microbiol. 16(4), 507-513 (2013).
10. Estrada-Pena A, de la Fuente J. The ecology of ticks and epidemiology of tick-borne viral diseases. Antiviral Res. 108, 104-128 (2014).
11. Bell-Sakyi L, Attoui H. Endogenous tick viruses and modulation of tick-borne pathogen growth. Front. Cell. Infect. Microbiol. 3, 25 (2013).
12. Nuttall PA. Molecular characterization of tick-virus interactions. Front. Biosci. (Landmark Ed) 14, 2466-2483 (2009).
13. Bell-Sakyi L, Kohl A, Bente DA, Fazakerley JK. Tick cell lines for study of Crimean-Congo hemorrhagic fever virus and other arboviruses. Vector Borne Zoonotic Dis. 12(9), 769-781 (2012).
14. Fernandez-Garcia MD, Negredo A, Papa A et al. European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012. Euro Surveill. 19(26), pii:20844 (2014).
15. Estrada-Pena A, Palomar AM, Santibanez P et al. Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010. Emerg. Infect. Dis. 18(1), 179-180 (2012).
16. Bouloy M. Molecular biology of phleboviruses. In: Bunyaviridae. Molecular and Cellular Biology. Plyusnin A, Elliot RM (Eds). Caister Academic Press (2011).
17. Oker-Blom N, Salminen A, Brummer-Korvenkontio M, Kaeaeriaeinen L, Weckstroem P. Isolation of some viruses other than typical tick-borne encephalitis viruses from ixodes ricinus ticks in Finland. Ann. Med. Exp. Biol. Fenn. 42, 109-112 (1964).
18. Boshra H, Lorenzo G, Busquets N, Brun A. Rift valley fever: recent insights into pathogenesis and prevention. J. Virol. 85(13), 6098-6105 (2011).
19. Bouloy M, Weber F. Molecular biology of Rift Valley fever virus. Open Virol. J. 4, 8-14 (2010).
20. Chevalier V, Pepin M, Plee L, Lancelot R. Rift Valley fever-a threat for Europe? Euro Surveill. 15(10), 19506 (2010).
21. Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ. Rift Valley fever virus. J. Am. Vet. Med. Assoc. 234(7), 883-893 (2009).
22. LaBeaud AD, Muchiri EM, Ndzovu M et al. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg. Infect. Dis. 14(8), 1240-1246 (2008).
23. Overby AK, Pettersson RF, Grunewald K, Huiskonen JT. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl Acad. Sci. USA 105(7), 2375-2379 (2008).
24. Crispin M, Harvey DJ, Bitto D et al. Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome. J. Virol. 88(17), 10244-10251 (2014).
25. Lozach PY, Kuhbacher A, Meier R et al. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10(1), 75-88 (2011).
26. Lozach PY, Mancini R, Bitto D et al. Entry of bunyaviruses into mammalian cells. Cell Host Microbe, 7(6), 488-499 (2010).
27. Meier R, Franceschini A, Horvath P et al. Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration. J. Virol. 88(15), 8565-8578 (2014).
28. Persson R, Pettersson RF. Formation and intracellular transport of a heterodimeric viral spike protein complex. J. Cell. Biol. 112(2), 257-266 (1991).
29. Pettersson RF, Hewlett MJ, Baltimore D, Coffin JM. The genome of Uukuniemi virus consists of three unique RNA segments. Cell 11(1), 51-63 (1977).
30. Overby AK, Pettersson RF, Neve EP. The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J. Virol. 81(7), 3198-3205 (2007).
31. Overby AK, Popov V, Neve EP, Pettersson RF. Generation and analysis of infectious virus-like particles of uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding. J. Virol. 80(21), 10428-10435 (2006).
32. von Bonsdorff CH, Pettersson R. Surface structure of Uukuniemi virus. J. Virol. 16(5), 1296-1307 (1975).
33. McMullan LK, Folk SM, Kelly AJ et al. A new phlebovirus associated with severe febrile illness in Missouri. N. Engl. J. Med. 367(9), 834-841 (2012).
34. Yu XJ, Liang MF, Zhang SY et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364(16), 1523-1532 (2011).
35. Liu S, Chai C, Wang C et al. Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev. Med. Virol. 24(2), 90-102 (2014).
36. Muehlenbachs A, Fata CR, Lambert AJ et al. Heartland virus-associated death in Tennessee. Clin. Infect. Dis. 59(6), 845-850 (2014).
37. Zhang YZ, Zhou DJ, Qin XC et al. The Ecology, Genetic Diversity, and Phylogeny of Huaiyangshan Virus in China. J. Virol. 86(5), 2864-2864 (2012).
38. Wang J, Selleck P, Yu M et al. Novel phlebovirus with zoonotic potential isolated from ticks, Australia. Emerg. Infect. Dis. 20(6), 1040-1043 (2014).
39. Marklewitz M, Handrick S, Grasse W et al. Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae. J. Virol. 85(17), 9227-9234 (2011).
40. Xu B, Liu L, Huang X et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 7(11), e1002369 (2011).
41. Palacios G, Savji N, Travassos da Rosa A et al. Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species. J. Virol. 87(6), 3187-3195 (2013).
42. Rezelj VV, Overby AK, Elliott RM. Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist. J. Virol. 89(9), 4849-4856 (2015).
43. Walter CT, Barr JN. Recent advances in the molecular and cellular biology of bunyaviruses. J. Gen. Virol. 92(Pt 11), 2467-2484 (2011).
44. Pinheiro FP, Travassos da Rosa AP, Gomes ML, LeDuc JW, Hoch AL. Transmission of Oropouche virus from man to hamster by the midge Culicoides paraensis. Science 215(4537), 1251-1253 (1982).
45. Guelmino DJ, Jevtic M. An epidemiological and hematological study of sandfly fever in Serbia. Acta Trop. 12(2), 179-182 (1955).
46. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am. J. Trop. Med. Hyg. 81(4), 675-678 (2009).
47. Horne KM, Vanlandingham DL. Bunyavirus-vector interactions. Viruses 6(11), 4373-4397 (2014).
48. Lima-Camara TN, Bruno RV, Luz PM et al. Dengue infection increases the locomotor activity of Aedes aegypti females. PLoS ONE 6(3), e17690 (2011).
49. Platt KB, Linthicum KJ, Myint KS, Innis BL, Lerdthusnee K, Vaughn DW. Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am. J. Trop. Med. Hyg. 57(2), 119-125 (1997).
50. Grimstad PR, Ross QE, Craig GB Jr. Aedes triseriatus (Diptera: Culicidae) and La Crosse virus. II. Modification of mosquito feeding behavior by virus infection. J. Med. Entomol. 17(1), 1-7 (1980).
51. Jackson BT, Brewster CC, Paulson SL. La Crosse virus infection alters blood feeding behavior in Aedes triseriatus and Aedes albopictus (Diptera: Culicidae). J. Med. Entomol. 49(6), 1424-1429 (2012).
52. Keating JA, Bhattacharya D, Rund SS et al. Mosquito protein kinase G phosphorylates flavivirus NS5 and alters flight behavior in aedes aegypti and anopheles gambiae. Vector Borne Zoonotic Dis. 13(8), 590-600 (2013).
53. Maltezou HC, Papa A. Crimean-Congo hemorrhagic fever: risk for emergence of new endemic foci in Europe? Travel Med. Infect. Dis. 8(3), 139-143 (2010).
54. Foulke RS, Rosato RR, French GR. Structural polypeptides of Hazara virus. J. Gen. Virol. 53(Pt 1), 169-172 (1981).
55. Watret GE, Elliott RM. The proteins and RNAs specified by Clo Mor virus, a Scottish Nairovirus. J. Gen. Virol. 66(Pt 11), 2513-2516 (1985).
56. Eifan S, Schnettler E, Dietrich I, Kohl A, Blomstrom AL. Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses 5(10), 2447-2468 (2013).
57. Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS, Doms RW. Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J. Virol. 81(12), 6632-6642 (2007).
58. Bergeron E, Vincent MJ, Nichol ST. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J. Virol. 81(23), 13271-13276 (2007).
59. Sanchez AJ, Vincent MJ, Nichol ST. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 76(14), 7263-7275 (2002).
60. Le May N, Bouloy M. Antiviral escape strategies developed by bunyaviruses pathogenic for humans. Front. Biosci. 4, 1065-1077 (2012).
61. Gommet C, Billecocq A, Jouvion G et al. Tissue tropism and target cells of NSsdeleted rift valley fever virus in live immunodeficient mice. PLoS Negl. Trop. Dis. 5(12), e1421 (2011).
62. Fontana J, Lopez-Montero N, Elliott RM, Fernandez JJ, Risco C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell Microbiol. 10(10), 2012-2028 (2008).
63. Shi X, Kohl A, Leonard VH, Li P, McLees A, Elliott RM. Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J. Virol. 80(16), 8089-8099 (2006).
64. Gerrard SR, Bird BH, Albarino CG, Nichol ST. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology 359(2), 459-465 (2007).
65. Bird BH, Albarino CG, Nichol ST. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology 362(1), 10-15 (2007).
66. Kading RC, Crabtree MB, Bird BH et al. Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl. Trop. Dis. 8(2), e2670 (2014).
67. Leger P, Lara E, Jagla B et al. Dicer-2-and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J. Virol. 87(3), 1631-1648 (2013).
68. Thomas D, Blakqori G, Wagner V et al. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J. Biol. Chem. 279(30), 31471-31477 (2004).
69. Reguera J, Malet H, Weber F, Cusack S. Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc. Natl Acad. Sci. USA 110(18), 7246-7251 (2013).
70. Li B, Wang Q, Pan X et al. Bunyamwera virus possesses a distinct nucleocapsid protein to facilitate genome encapsidation. Proc. Natl Acad. Sci. USA 110(22), 9048-9053 (2013).
71. Ariza A, Tanner SJ, Walter CT et al. Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization. Nucleic Acids Res. 41(11), 5912-5912 (2013).
72. Dong H, Li P, Bottcher B, Elliott RM, Dong C. Crystal structure of Schmallenberg orthobunyavirus nucleoprotein-RNA complex reveals a novel RNA sequestration mechanism. RNA 19(8), 1129-1136 (2013).
73. Dong H, Li P, Elliott RM, Dong C. Structure of Schmallenberg orthobunyavirus nucleoprotein suggests a novel mechanism of genome encapsidation. J. Virol. 87(10), 5593-5601 (2013).
74. Jiao L, Ouyang S, Liang M et al. Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential. J. Virol. 87(12), 6829-6829 (2013).
75. Niu F, Shaw N, Wang YE et al. Structure of the Leanyer orthobunyavirus nucleoprotein-RNA complex reveals unique architecture for RNA encapsidation. Proc. Natl Acad. Sci. USA 110(22), 9054-9059 (2013).
76. Olal D, Dick A, Woods VL Jr et al. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein. Nucleic Acids Res. 42(9), 6025-6037 (2014).
77. Raymond DD, Piper ME, Gerrard SR, Smith JL. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation. Proc. Natl Acad. Sci. USA 107(26), 11769-11774 (2010).
78. Carter SD, Surtees R, Walter CT et al. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Virol. 86(20), 10914-10923 (2012).
79. Guo Y, Wang W, Ji W et al. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc. Natl Acad. Sci. USA 109(13), 5046-5051 (2012).
80. Wang Y, Dutta S, Karlberg H et al. Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. J. Virol. 86(22), 12294-12303 (2012).
81. Reguera J, Cusack S, Kolakofsky D. Segmented negative strand RNA virus nucleoprotein structure. Curr. Opin. Virol. 5, 7-15 (2014).
82. Ferron F, Li Z, Danek EI et al. The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes. PLoS Pathog. 7(5), e1002030 (2011).
83. Raymond DD, Piper ME, Gerrard SR, Skiniotis G, Smith JL. Phleboviruses encapsidate their genomes by sequestering RNA bases. Proc. Natl Acad. Sci. USA 109(47), 19208-19213 (2012).
84. Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ. Threedimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J. Virol. 82(21), 10341-10348 (2008).
85. Huiskonen JT, Overby AK, Weber F, Grunewald K. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J. Virol. 83(8), 3762-3769 (2009).
86. Sherman MB, Freiberg AN, Holbrook MR, Watowich SJ. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology 387(1), 11-15 (2009).
87. Bowden TA, Bitto D, McLees A, Yeromonahos C, Elliott RM, Huiskonen JT. Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog. 9(5), e1003374 (2013).
88. Estrada DF, De Guzman RN. Structural characterization of the Crimean-Congo hemorrhagic fever virus Gn tail provides insight into virus assembly. J. Biol. Chem. 286(24), 21678-21686 (2011).
89. Dessau M, Modis Y. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc. Natl Acad. Sci. USA 110(5), 1696-1701 (2013).
90. Kanai R, Kar K, Anthony K et al. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 80(22), 11000-11008 (2006).
91. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972), 313-319 (2004).
92. Garry CE, Garry RF. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor. Biol. Med. Model 1 10 (2004).
93. Tischler ND, Gonzalez A, Perez-Acle T, Rosemblatt M, Valenzuela PD. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J. Gen. Virol. 86(Pt 11), 2937-2937 (2005).
94. Plassmeyer ML, Soldan SS, Stachelek KM, Martin-Garcia J, Gonzalez-Scarano F. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry. Virology 338(1), 121-132 (2005).
95. Shi X, Goli J, Clark G, Brauburger K, Elliott RM. Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein. J. Gen. Virol. 90(Pt 10), 2483-2492 (2009).
96. Plassmeyer ML, Soldan SS, Stachelek KM, Roth SM, Martin-Garcia J, Gonzalez-Scarano F. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology 358(2), 273-282 (2007).
97. Soldan SS, Hollidge BS, Wagner V, Weber F, Gonzalez-Scarano F. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology 404(2), 139-147 (2010).
98. Jacoby DR, Cooke C, Prabakaran I, Boland J, Nathanson N, Gonzalez-Scarano F. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology 193(2), 993-996 (1993).
99. Rusu M, Bonneau R, Holbrook MR et al. An assembly model of rift valley Fever virus. Front. Microbiol. 3, 254 (2012).
100. Lowen AC, Noonan C, McLees A, Elliott RM. Efficient bunyavirus rescue from cloned cDNA. Virology 330(2), 493-500 (2004).
101. Bridgen A, Elliott RM. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl Acad. Sci. USA 93(26), 15400-15404 (1996).
102. Blakqori G, Weber F. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J. Virol. 79(16), 10420-10428 (2005).
103. Brennan B, Li P, Zhang S et al. Reverse genetics system for severe Fever with thrombocytopenia syndrome virus. J. Virol. 89(6), 3026-3037 (2015).
104. Ikegami T, Won S, Peters CJ, Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 80(6), 2933-2933 (2006).
105. Elliott RM, Blakqori G, van Knippenberg IC et al. Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe. J. Gen. Virol. 94(Pt 4), 851-859 (2013).
106. Moutailler S, Roche B, Thiberge JM, Caro V, Rougeon F, Failloux AB. Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Negl. Trop. Dis. 5(5), e1156 (2011).
107. Coffey LL, Vignuzzi M. Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J. Virol. 85(2), 1025-1035 (2011).
108. Coffey LL, Vasilakis N, Brault AC, Powers AM, Tripet F, Weaver SC. Arbovirus evolution in vivo is constrained by host alternation. Proc. Natl Acad. Sci. USA 105(19), 6970-6970 (2008).
109. Schiller B, Hykollari A, Yan S, Paschinger K, Wilson IB. Complicated N-linked glycans in simple organisms. Biol. Chem. 393(8), 661-673 (2012).
110. Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell. Biol. 13(7), 448-462 (2012).
111. Dejnirattisai W, Webb AI, Chan V et al. Lectin switching during dengue virus infection. J. Infect. Dis. 203(12), 1775-1783 (2011).
112. Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A. Pathogenesis of flavivirus infections: using and abusing the host cell. Cell Host Microbe 5(4), 318-328 (2009).
113. Butler M, Spearman M. The choice of mammalian cell host and possibilities for glycosylation engineering. Curr. Opin. Biotechnol. 30C, 107-112 (2014).
114. Hofmann H, Li X, Zhang X et al. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J. Virol. 87(8), 4384-4394 (2013).
115. Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79(21), 13262-13274 (2005).
116. Mondotte JA, Lozach PY, Amara A, Gamarnik AV. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J. Virol. 81(13), 7136-7148 (2007).
117. Hacker K, White L, de Silva AM. N-linked glycans on dengue viruses grown in mammalian and insect cells. J. Gen. Virol. 90(Pt 9), 2097-2106 (2009).
118. Hofmann H, Pohlmann S. DC-SIGN: access portal for sweet viral killers. Cell Host Microbe 10(1), 5-7 (2011).
119. Nfon CK, Marszal P, Zhang S, Weingartl HM. Innate immune response to Rift Valley fever virus in goats. PLoS Negl. Trop. Dis. 6(4), e1623 (2012).
120. Canavoso LE, Jouni ZE, Karnas KJ, Pennington JE, Wells MA. Fat metabolism in insects. Annu. Rev. Nutr. 21, 23-46 (2001).
121. Stanley-Samuelson DW, Jurenka RA, Cripps C, Blomquist GJ, de Renobales M. Fatty acids in insects: Composition, metabolism, and biological significance. Arch. Insect. Biochem. Physiol. 9(1), 1-33 (1988).
122. Gimpl G, Klein U, Reilander H, Fahrenholz F. Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterolcyclodextrin complex. Biochemistry 34(42), 13794-13801 (1995).
123. Marheineke K, Grunewald S, Christie W, Reilander H. Lipid composition of Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) insect cells used for baculovirus infection. FEBS Lett. 441(1), 49-52 (1998).
124. Gahmberg N. Characterization of two recombination-complementation groups of Uukuniemi virus temperature-sensitive mutants. J. Gen. Virol. 65(Pt 6), 1079-1090 (1984).
125. Saluzzo JF, Smith JF. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. Vaccine 8(4), 369-375 (1990).
126. Kakach LT, Wasmoen TL, Collett MS. Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J. Virol. 62(3), 826-833 (1988).
127. Suzich JA, Kakach LT, Collett MS. Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment. J. Virol. 64(4), 1549-1555 (1990).
128. Weingartl HM, Zhang S, Marszal P, McGreevy A, Burton L, Wilson WC. Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS ONE 9(1), e87385 (2014).
129. Kreher F, Tamietti C, Gommet C et al. The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts. Emerg. Microbes Infect. 3(10), e71 (2014).
130. Gillespie RD, Mbow ML, Titus RG. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol. 22(7), 319-331 (2000).
131. Heinze DM, Carmical JR, Aronson JF, Thangamani S. Early immunologic events at the tick-host interface. PLoS ONE 7(10), e47301 (2012).
132. Abdeladhim M, Kamhawi S, Valenzuela JG. What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity. Infect. Genet. Evol. (28, 691-703 (2014).
133. Lehiy CJ, Drolet BS. The salivary secretome of the biting midge, Culicoides sonorensis. Peer J. 2, e426 (2014).
134. Teixeira C, Gomes R, Oliveira F et al. Characterization of the early inflammatory infiltrate at the feeding site of infected sand flies in mice protected from vector-transmitted Leishmania major by exposure to uninfected bites. PLoS Negl. Trop. Dis. 8(4), e2781 (2014).
135. Ockenfels B, Michael E, McDowell MA. Meta-analysis of the effects of insect vector saliva on host immune responses and infection of vector-transmitted pathogens: a focus on leishmaniasis. PLoS Negl. Trop. Dis. 8(10), e3197 (2014).
136. Schneider BS, Higgs S. The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans. R. Soc. Trop. Med. Hyg. 102(5), 400-408 (2008).
137. Schneider BS, Soong L, Coffey LL, Stevenson HL, McGee CE, Higgs S. Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS ONE 5(7), e11704 (2010).
138. Surasombatpattana P, Patramool S, Luplertlop N, Yssel H, Misse D. Aedes aegypti saliva enhances dengue virus infection of human keratinocytes by suppressing innate immune responses. J. Invest. Dermatol. 132(8), 2103-2105 (2012).
139. Reagan KL, Machain-Williams C, Wang T, Blair CD. Immunization of mice with recombinant mosquito salivary protein D7 enhances mortality from subsequent West Nile virus infection via mosquito bite. PLoS Negl. Trop. Dis. 6(12), e1935 (2012).
140. Limesand KH, Higgs S, Pearson LD, Beaty BJ. Potentiation of vesicular stomatitis New Jersey virus infection in mice by mosquito saliva. Parasite Immunol. 22(9), 461-467 (2000).
141. Limesand KH, Higgs S, Pearson LD, Beaty BJ. Effect of mosquito salivary gland treatment on vesicular stomatitis New Jersey virus replication and interferon alpha/beta expression in vitro. J. Med. Entomol. 40(2), 199-205 (2003).
142. Reisen WK, Chiles RE, Kramer LD, Martinez VM, Eldridge BF. Method of infection does not alter response of chicks and house finches to western equine encephalomyelitis and St. Louis encephalitis viruses. J. Med. Entomol. 37(2), 250-258 (2000).
143. Schneider BS, Soong L, Girard YA, Campbell G, Mason P, Higgs S. Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunol. 19(1), 74-82 (2006).
144. Styer LM, Bernard KA, Kramer LD. Enhanced early West Nile virus infection in young chickens infected by mosquito bite: effect of viral dose. Am. J. Trop. Med. Hyg. 75(2), 337-345 (2006).
145. Edwards JF, Higgs S, Beaty BJ. Mosquito feeding-induced enhancement of Cache Valley Virus (Bunyaviridae) infection in mice. J. Med. Entomol. 35(3), 261-265 (1998).
146. Le Coupanec A, Babin D, Fiette L et al. Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity. PLoS Negl. Trop. Dis. 7(6), e2237 (2013).
147. Osorio JE, Godsey MS, Defoliart GR, Yuill TM. La Crosse viremias in white-tailed deer and chipmunks exposed by injection or mosquito bite. Am. J. Trop. Med. Hyg. 54(4), 338-342 (1996).
148. Sim S, Jupatanakul N, Dimopoulos G. Mosquito immunity against arboviruses. Viruses 6(11), 4479-4504 (2014).
149. Buchmann K. Evolution of innate immunity: clues from invertebrates via fish to mammals. Front. Immunol. 5, 459 (2014).
150. Lavine MD, Strand MR. Insect hemocytes and their role in immunity. Insect. Biochem. Mol. Biol. 32(10), 1295-1309 (2002).
151. Blair CD, Olson KE. The Role of RNA Interference (RNAi) in arbovirus-vector interactions. Viruses 7(2), 820-843 (2015).
152. Carissimo G, Pondeville E, McFarlane M et al. Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiota. Proc. Natl Acad. Sci. USA (2014).
153. Minard G, Mavingui P, Moro CV. Diversity and function of bacterial microbiota in the mosquito holobiont. Parasit. Vectors 6, 146 (2013).
154. Ramirez JL, Souza-Neto J, Torres Cosme R et al. Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence. PLoS Negl. Trop. Dis. 6(3), e1561 (2012).
155. Hedges LM, Brownlie JC, O'Neill SL, Johnson KN. Wolbachia and virus protection in insects. Science 322(5902), 702 (2008).
156. Scarborough CL, Ferrari J, Godfray HC. Aphid protected from pathogen by endosymbiont. Science 310(5755), 1781 (2005).
157. Kambris Z, Cook PE, Phuc HK, Sinkins SP. Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes. Science 326(5949), 134-136 (2009).
158. Hedges LM, Johnson KN. Induction of host defence responses by Drosophila C virus. J. Gen. Virol. 89(Pt 6), 1497-1501 (2008).
159. Moreira LA, Iturbe-Ormaetxe I, Jeffery JA et al. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell 139(7), 1268-1278 (2009).
160. Hussain M, Lu G, Torres S et al. Effect of Wolbachia on replication of West Nile virus in a mosquito cell line and adult mosquitoes. J. Virol. 87(2), 851-858 (2013).
161. Heath WR, Carbone FR. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat. Immunol. 14(10), 978-985 (2013).
162. Peyrefitte CN, Perret M, Garcia S et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus-and Dugbe virus-infected antigen-presenting cells. J. Gen. Virol. 91(Pt 1), 189-198 (2010).
163. Connolly-Andersen AM, Douagi I, Kraus AA, Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 390(2), 157-162 (2009).
164. McElroy AK, Nichol ST. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology 422(1), 6-12 (2012).
165. Miller MJ, Hejazi AS, Wei SH, Cahalan MD, Parker I. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl Acad. Sci. USA 101(4), 998-1003 (2004).
166. Lihoradova O, Kalveram B, Indran SV et al. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. J. Virol. 86(14), 7650-7661 (2012).
167. de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ. Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J. Virol. 86(24), 13767-13771 (2012).
168. Pietrantoni A, Fortuna C, Remoli ME, Ciufolini MG, Superti F. Bovine lactoferrin inhibits toscana virus infection by binding to heparan sulphate. Viruses 7(2), 480-495 (2015).
169. Sun Y, Qi Y, Liu C et al. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J. Virol. 88(1), 237-248 (2014).
170. Xiao X, Feng Y, Zhu Z, Dimitrov DS. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411(2), 253-258 (2011).
171. Lozach PY, Huotari J, Helenius A. Latepenetrating viruses. Curr. Opin. Virol. 1(1), 35-43 (2011).
172. Bangphoomi N, Takenaka-Uema A, Sugi T, Kato K, Akashi H, Horimoto T. Akabane virus utilizes alternative endocytic pathways to entry into mammalian cell lines. J. Vet. Med. Sci. 76(11), 1471-1478 (2014).
173. Hollidge BS, Nedelsky NB, Salzano MV, Fraser JW, Gonzalez-Scarano F, Soldan SS. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J. Virol. 86(15), 7988-7988 (2012).
174. Santos RI, Rodrigues AH, Silva ML et al. Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification. Virus Res. 138(1-2), 139-143 (2008).
175. Simon M, Johansson C, Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH-and cholesterol-dependent. J. Gen. Virol. 90(Pt 1), 210-215 (2009).
176. Shtanko O, Nikitina RA, Altuntas CZ, Chepurnov AA, Davey RA. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog. 10(9), e1004390 (2014).
177. Garrison AR, Radoshitzky SR, Kota KP et al. Crimean-Congo hemorrhagic fever virus utilizes a clathrin-and early endosomedependent entry pathway. Virology 444(1-2), 45-54 (2013).
178. Simon M, Johansson C, Lundkvist A, Mirazimi A. Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 385(2), 313-322 (2009).
179. de Boer SM, Kortekaas J, Spel L, Rottier PJ, Moormann RJ, Bosch BJ. Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J. Virol. 86(24), 13642-13652 (2012).
180. Harmon B, Schudel BR, Maar D et al. Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J. Virol. 86(23), 12954-12970 (2012).
181. Filone CM, Hanna SL, Caino MC, Bambina S, Doms RW, Cherry S. Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon. PLoS ONE 5(11), e15483 (2010).
182. Svajger U, Anderluh M, Jeras M, Obermajer N. C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal. 22(10), 1397-1405 (2010).
183. Cureton DK, Harbison CE, Cocucci E, Parrish CR, Kirchhausen T. Limited transferrin receptor clustering allows rapid diffusion of canine parvovirus into clathrin endocytic structures. J. Virol. 86(9), 5330-5340 (2012).
184. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydratespecific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 10(10), 1081-1088 (2009).
185. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NFkappaB. Immunity 26(5), 605-616 (2007).
186. Lozach PY, Burleigh L, Staropoli I et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DCSIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280(25), 23698-23708 (2005).
187. Azad AK, Torrelles JB, Schlesinger LS. Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells. J. Leukoc. Biol. 84(6), 1594-1603 (2008).
188. Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J. Virol. 87(21), 11504-11515 (2013).
189. Braulke T, Bonifacino JS. Sorting of lysosomal proteins. Biochim. Biophys. Acta 1793(4), 605-614 (2009).
190. Cambi A, Beeren I, Joosten B, Fransen JA, Figdor CG. The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism. Eur. J. Immunol. 39(7), 1923-1923 (2009).
191. Cambi A, de Lange F, van Maarseveen NM et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J. Cell. Biol. 164(1), 145-155 (2004).
192. Scott CC, Gruenberg J. Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. Bioessays 33(2), 103-110 (2011).
193. Scott CC, Vacca F, Gruenberg J. Endosome maturation, transport and functions. Semin. Cell. Dev. Biol. 31, 2-10 (2014).
194. Liu L, Celma CC, Roy P. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Virol. J. 5, 82 (2008).
195. Wang T, Ming Z, Xiaochun W, Hong W. Rab7: role of its protein interaction cascades in endo-lysosomal traffic. Cell Signal. 23(3), 516-521 (2011).
196. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, Helenius A. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 378(1), 21-33 (2008).
197. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J. Virol. 82(15), 7677-7687 (2008).
198. Vaney MC, Rey FA. Class II enveloped viruses. Cell. Microbiol. 13(10), 1451-1459 (2011).
199. Hopkins KC, McLane LM, Maqbool T, Panda D, Gordesky-Gold B, Cherry S. A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral replication by limiting the pools of Dcp2-accessible targets for cap-snatching. Genes Dev. 27(13), 1511-1525 (2013).